KEYTRUDA® (pembrolizumab) - Official Site
WEBKEYTRUDA is a prescription medicine used to treat a kind of uterine cancer called advanced endometrial carcinoma. KEYTRUDA may be used with the chemotherapy medicines carboplatin and paclitaxel, and then KEYTRUDA may be used alone, in adults: when your cancer has spread (advanced), or; if your cancer has returned. KEYTRUDA may be used alone in ...
Pembrolizumab - Wikipedia
WEBPembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.
Keytruda (pembrolizumab): Side effects, uses, cost, and more
WEBJun 27, 2024 · Keytruda is a brand-name intravenous infusion prescribed for certain types of cancer. Keytruda contains the active ingredient pembrolizumab and is a type of immunotherapy. The Food and Drug...
Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBSep 9, 2024 · Pembrolizumab (brand name: Keytruda) is a cancer medicine given into your vein as a slow intravenous (IV) infusion that usually takes about 30 minutes. You will most likely receive this treatment in an outpatient clinic or hospital setting every 3 or 6 weeks.
Pembrolizumab - NCI - National Cancer Institute
WEBIt is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells. US Brand Name (s) Keytruda. FDA Approved. Yes. FDA label information for this drug is available at DailyMed.
Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic
WEBJul 1, 2024 · Description and Brand Names. Drug information provided by: Merative, Micromedex® US Brand Name. Keytruda; Descriptions. Pembrolizumab injection is used to treat melanoma (a type of skin cancer) that has spread or cannot be removed by surgery.
pembrolizumab (KEYTRUDA) | FDA - U.S. Food and Drug …
WEBOn August 5, 2016, the U. S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA injection, Merck Sharp & Dohme Corp.) for the treatment of patients with...
FDA approves pembrolizumab for high-risk early-stage triple …
WEBOn July 26, 2021, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for high-risk, early-stage, triple-negative breast cancer (TNBC) in combination with chemotherapy as...
Pembrolizumab: Uses, Dosage, Side Effects & Warning - Drugs.com
WEBMar 26, 2024 · Pembrolizumab (brand name: Keytruda) is a cancer medicine given into your vein as a slow intravenous (IV) infusion that usually takes about 30 minutes. You will most likely receive this treatment in an outpatient …
Pembrolizumab (Keytruda): Uses & Side Effects - Cleveland Clinic
WEBPembrolizumab is a monoclonal antibody that treats certain types of cancer. The brand name of this medication is Keytruda®. A healthcare provider will give you this infusion in a hospital or clinic setting.
- Some results have been removed
Skip to content